Skip to Main Content

Advertisement

Skip Nav Destination

Rivaroxaban Prevents Cancer-Associated Venous Thromboembolism

December 30, 2021

Alok Khorana, MD, shares results from the CASSINI trial, which found that treatment with rivaroxaban reduced the risk of venous thromboembolism in patients receiving cancer treatment.

Advertisement

Connect with us:

CURRENT ISSUE
September 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement